US Stock MarketDetailed Quotes

GENE Genetic Technologies

Watchlist

1.690
-0.080-4.52%

Close Jun 7 16:00 ET

1.690
+0.000+0.01%

Post 18:44 ET

7.45MMarket Cap-11118P/E (TTM)

Genetic Technologies Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual

YOY

Hide blank lines

(Q3)Mar 31, 2024

(Q2)Dec 31, 2023

(Q1)Sep 30, 2023

(FY)Jun 30, 2023

(Q4)Jun 30, 2023

(Q3)Mar 31, 2023

(Q2)Dec 31, 2022

(Q1)Sep 30, 2022

(FY)Jun 30, 2022

(Q4)Jun 30, 2022

Operating Cash Flow (Indirect Method)

Cash flow from continuing operating activities

Cash from discontinued investing activities

Investing cash flow

Cash flow from continuing investing activities

0.00%-1K

39.70%110.98K

95.71%-21K

90.99%-311.94K

-1,116.41%-282.94K

-1K

146.42%79.45K

85.88%-489K

-362.29%-3.46M

116.70%27.84K

Net PPE purchase and sale

0.00%-1K

-6,250.00%-7.24K

-600.00%-21K

72.54%-17.55K

124.40%11.45K

---1K

99.75%-114

-50.00%-3K

91.46%-63.93K

71.85%-46.93K

Net intangibles purchase and sale

--0

----

--0

----

--0

---32.87K

----

Net business purchase and sale

--0

85.70%-486.19K

-781.17%-486.19K

--0

-100.29%-187

85.96%-486K

---3.4M

--71.38K

Net investment purchase and sale

--0

----

--0

----

--0

----

--0

----

Cash from discontinued investing activities

Investing cash flow

0.00%-1K

39.70%110.98K

95.71%-21K

90.99%-311.94K

-1,116.41%-282.94K

---1K

146.42%79.45K

85.88%-489K

-362.29%-3.46M

116.70%27.84K

Financing cash flow

Cash flow from continuing financing activities

-90.49%601K

-5.16%-175.08K

2,221.36%5.92M

5.32M

6.32M

-166.48K

-102.04%-279.06K

Net issuance payments of debt

--601K

-3.82%-172.85K

--0

-25.25%-336.4K

---937.4K

--0

---166.48K

--0

-13.38%-268.59K

----

Net common stock issuance

--0

----

--0

--7.17M

----

--0

----

Cash dividends paid

--0

----

Proceeds from stock option exercised by employees

--0

----

--0

----

--0

----

--0

----

Net other financing activities

----

-8,646.04%-916.06K

----

---852K

----

99.46%-10.47K

----

Cash from discontinued financing activities

Financing cash flow

-90.49%601K

-5.16%-175.08K

--0

2,221.36%5.92M

--5.32M

--6.32M

-977.92%-166.48K

--0

-102.04%-279.06K

----

Net cash flow

Beginning cash position

----

-38.35%4.9M

-33.07%7.85M

-43.88%11.73M

----

345.38%5.05M

-49.53%7.95M

-43.87%11.73M

47.05%20.9M

-50.62%11.35M

Current changes in cash

-66.58%1.77M

59.49%-1.14M

24.11%-2.96M

56.22%-4.12M

80.50%-5.91M

-60.84%5.29M

-28.79%-2.81M

27.84%-3.9M

-241.45%-9.4M

-1,216.00%-30.3M

Effect of exchange rate changes

-90.41%14K

67.38%-29.12K

-96.40%4K

2.73%234.96K

74.78%245.96K

241.75%146K

-68.68%-89.27K

-54.13%111K

434.89%228.73K

-36.25%140.73K

End cash Position

-83.00%1.78M

-26.08%3.73M

-38.35%4.9M

-33.07%7.85M

-7.66%10.48M

-62.65%5.05M

-49.53%7.95M

-43.88%11.73M

Free cash flow

-148.74%-2.56M

60.29%-1.08M

13.30%-2.96M

-69.22%-9.74M

-846.13%-3.08M

49.90%-1.03M

-21.35%-2.72M

-75.84%-3.41M

18.29%-5.76M

120.41%412.75K

Currency Unit

AUD

Accounting Standards

US-GAAP

Audit Opinions

Unqualified Opinion with Explanatory Notes

	(Q3)Mar 31, 2024	(Q2)Dec 31, 2023	(Q1)Sep 30, 2023	(FY)Jun 30, 2023	(Q4)Jun 30, 2023	(Q3)Mar 31, 2023	(Q2)Dec 31, 2022	(Q1)Sep 30, 2022	(FY)Jun 30, 2022	(Q4)Jun 30, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
Cash from discontinued investing activities
Investing cash flow
Cash flow from continuing investing activities	0.00%-1K	39.70%110.98K	95.71%-21K	90.99%-311.94K	-1,116.41%-282.94K	-1K	146.42%79.45K	85.88%-489K	-362.29%-3.46M	116.70%27.84K
Net PPE purchase and sale	0.00%-1K	-6,250.00%-7.24K	-600.00%-21K	72.54%-17.55K	124.40%11.45K	---1K	99.75%-114	-50.00%-3K	91.46%-63.93K	71.85%-46.93K
Net intangibles purchase and sale	--0	----	--0	--0	--0	--0	----	--0	---32.87K	----
Net business purchase and sale	--0	--0	--0	85.70%-486.19K	-781.17%-486.19K	--0	-100.29%-187	85.96%-486K	---3.4M	--71.38K
Net investment purchase and sale	--0	----	--0	----	----	--0	----	--0	----	----
Cash from discontinued investing activities
Investing cash flow	0.00%-1K	39.70%110.98K	95.71%-21K	90.99%-311.94K	-1,116.41%-282.94K	---1K	146.42%79.45K	85.88%-489K	-362.29%-3.46M	116.70%27.84K
Financing cash flow
Cash flow from continuing financing activities	-90.49%601K	-5.16%-175.08K	0	2,221.36%5.92M	5.32M	6.32M	-166.48K	0	-102.04%-279.06K
Net issuance payments of debt	--601K	-3.82%-172.85K	--0	-25.25%-336.4K	---937.4K	--0	---166.48K	--0	-13.38%-268.59K	----
Net common stock issuance	--0	----	--0	--7.17M	--7.17M	--7.17M	----	--0	--0	----
Cash dividends paid	--0	--0	--0	--0	--0	--0	--0	--0	--0	----
Proceeds from stock option exercised by employees	--0	----	--0	----	----	--0	----	--0	----	----
Net other financing activities	----	----	----	-8,646.04%-916.06K	----	---852K	----	----	99.46%-10.47K	----
Cash from discontinued financing activities
Financing cash flow	-90.49%601K	-5.16%-175.08K	--0	2,221.36%5.92M	--5.32M	--6.32M	-977.92%-166.48K	--0	-102.04%-279.06K	----
Net cash flow
Beginning cash position	----	-38.35%4.9M	-33.07%7.85M	-43.88%11.73M	----	345.38%5.05M	-49.53%7.95M	-43.87%11.73M	47.05%20.9M	-50.62%11.35M
Current changes in cash	-66.58%1.77M	59.49%-1.14M	24.11%-2.96M	56.22%-4.12M	80.50%-5.91M	-60.84%5.29M	-28.79%-2.81M	27.84%-3.9M	-241.45%-9.4M	-1,216.00%-30.3M
Effect of exchange rate changes	-90.41%14K	67.38%-29.12K	-96.40%4K	2.73%234.96K	74.78%245.96K	241.75%146K	-68.68%-89.27K	-54.13%111K	434.89%228.73K	-36.25%140.73K
End cash Position	-83.00%1.78M	-26.08%3.73M	-38.35%4.9M	-33.07%7.85M	-33.07%7.85M	-7.66%10.48M	-62.65%5.05M	-49.53%7.95M	-43.88%11.73M	-43.88%11.73M
Free cash flow	-148.74%-2.56M	60.29%-1.08M	13.30%-2.96M	-69.22%-9.74M	-846.13%-3.08M	49.90%-1.03M	-21.35%-2.72M	-75.84%-3.41M	18.29%-5.76M	120.41%412.75K
Currency Unit	AUD	AUD	AUD	AUD	AUD	AUD	AUD	AUD	AUD	AUD
Accounting Standards	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP
Audit Opinions	--	--	--	Unqualified Opinion with Explanatory Notes	--	--	--	--	Unqualified Opinion with Explanatory Notes	--

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List

Overall